IgA nephropathy: an interesting autoimmune kidney disease
A Rajasekaran, BA Julian, DV Rizk - The American journal of the medical …, 2021 - Elsevier
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis
worldwide. It is a leading cause of chronic kidney disease and progresses to end-stage …
worldwide. It is a leading cause of chronic kidney disease and progresses to end-stage …
IgA nephropathy
Abstract Globally, IgA nephropathy (IgAN) is the most common primary glomerulonephritis
that can progress to renal failure. The exact pathogenesis of IgAN is not well defined, but …
that can progress to renal failure. The exact pathogenesis of IgAN is not well defined, but …
IgA nephropathy
RJ Wyatt, BA Julian - New England Journal of Medicine, 2013 - Mass Medical Soc
IgA nephropathy is a common glomerular disease that is an important cause of kidney
failure. This review discusses advances in the therapy and understanding of the molecular …
failure. This review discusses advances in the therapy and understanding of the molecular …
[HTML][HTML] Glycans in the immune system and the altered glycan theory of autoimmunity: a critical review
E Maverakis, K Kim, M Shimoda, ME Gershwin… - Journal of …, 2015 - Elsevier
Herein we will review the role of glycans in the immune system. Specific topics covered
include: the glycosylation sites of IgE, IgM, IgD, IgE, IgA, and IgG; how glycans can encode …
include: the glycosylation sites of IgE, IgM, IgD, IgE, IgA, and IgG; how glycans can encode …
Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins
L Liu - Journal of pharmaceutical sciences, 2015 - Elsevier
Understanding the impact of glycosylation and keeping a close control on glycosylation of
product candidates are required for both novel and biosimilar monoclonal antibodies (mAbs) …
product candidates are required for both novel and biosimilar monoclonal antibodies (mAbs) …
[HTML][HTML] New developments in the genetics, pathogenesis, and therapy of IgA nephropathy
R Magistroni, VD D'Agati, GB Appel, K Kiryluk - Kidney international, 2015 - Elsevier
Recent years have brought notable progress in the field of IgA nephropathy. Here, we
highlight important new directions and latest developments, including successful discovery …
highlight important new directions and latest developments, including successful discovery …
The function of immunoglobulin A in immunity
JM Woof, MA Kerr - The Journal of Pathology: A Journal of the …, 2006 - Wiley Online Library
The vast surfaces of the gastrointestinal, respiratory, and genitourinary tracts represent
major sites of potential attack by invading micro‐organisms. Immunoglobulin A (IgA), as the …
major sites of potential attack by invading micro‐organisms. Immunoglobulin A (IgA), as the …
Concepts and principles of O-linked glycosylation
PV Steen, PM Rudd, RA Dwek… - Critical reviews in …, 1998 - Taylor & Francis
The biosynthesis, structures, and functions of O-glycosylation, as a complex
posttranslational event, is reviewed and compared for the various types of O-glycans. Mucin …
posttranslational event, is reviewed and compared for the various types of O-glycans. Mucin …
Henoch-Schönlein purpura in children: report of 100 patients and review of the literature
FT Saulsbury - Medicine, 1999 - journals.lww.com
Vol. 78, No. 6 Page 1 0025-7974/99/7806-0395/0 MEDICINE 978: 395-409, 1999 Copyright C
1999 by Lippincott Williams & Wilkins, Inc. Vol. 78, No. 6 Printed in USA Henoch-Schönlein …
1999 by Lippincott Williams & Wilkins, Inc. Vol. 78, No. 6 Printed in USA Henoch-Schönlein …
Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity
H Suzuki, R Fan, Z Zhang, R Brown… - The Journal of …, 2009 - Am Soc Clin Investig
IgA nephropathy (IgAN) is characterized by circulating immune complexes composed of
galactose-deficient IgA1 and a glycan-specific IgG antibody. These immune complexes …
galactose-deficient IgA1 and a glycan-specific IgG antibody. These immune complexes …